Experience in performing robot-assisted radical prostatectomy in patients after heart transplantation
- Authors: Mosoyan M.S.1, Shelipanov D.A.1, Fedotov P.A.1, Fedorov D.A.1, Simonenko M.A.1
-
Affiliations:
- FGBU NMRC named after V.A. Almazov of the Ministry of Health of the Russian Federation
- Issue: No 3 (2023)
- Pages: 92-97
- Section: ONCOUROLOGY
- URL: https://journal-vniispk.ru/1728-2985/article/view/258076
- DOI: https://doi.org/10.18565/urology.2023.3.92-97
- ID: 258076
Cite item
Open Access
Access granted
Subscription Access
Abstract
Introduction. Prostate cancer (PCa) occupies a leading position in the structure of oncological morbidity and mortality and is an urgent problem of modern oncourology. In recipients after organ transplantation, due to the intake of immunosuppressants, the risk of aggressive forms of cancer increases, which necessitates active treatment. In the world, there is not enough data on the radical treatment of PCa in patients after heart transplantation (HT), especially on surgical treatment. We present the first experience in Russia and Eastern Europe of 3 robot-assisted radical prostatectomy for localized PCa in patients after HT.
Materials and methods. The procedures were performed from February 2021 to November 2021 at the FGBU NMRC named after V.A. Almazov. Preoperative preparation, as well as postoperative management of patients was carried out jointly by urologists and transplant cardiologists.
Results. The main demographic, perioperative indicators, as well as oncological and non-oncological outcomes are presented. All patients were discharged from the hospital in a satisfactory condition. During the follow-up period, there were no biochemical recurrences of PCa. Early urinary continence in all three patients was satisfactory.
Conclusion. Thus, robot-assisted radical prostatectomy in patients after HT is a technically feasible, effective, and safe treatment for PCa. The comparative studies with prolonged follow-up are needed.
Full Text
##article.viewOnOriginalSite##About the authors
M. S. Mosoyan
FGBU NMRC named after V.A. Almazov of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: moso03@yandex.ru
SPIN-code: 5716-9089
Scopus Author ID: 57208982777
Ph.D., MD, Head of the Department of Urology with Department of Urology with a course of Robotic surgery with a clinic; professor at the Department of Urology with a course of Robotic surgery with a clinic, Chief of the Center of Robotic Surgery
Russian Federation, Saint PetersburgD. A. Shelipanov
FGBU NMRC named after V.A. Almazov of the Ministry of Health of the Russian Federation
Email: shelipanov_da@almazovcentre.ru
Ph.D., Head of the Department of Urology
Russian Federation, Saint PetersburgP. A. Fedotov
FGBU NMRC named after V.A. Almazov of the Ministry of Health of the Russian Federation
Email: drheart@mail.ru
ORCID iD: 0000-0002-7452-1971
Ph.D., Head of the Research Laboratory of High-Tech treatment methods of heart failure
Russian Federation, Saint PetersburgD. A. Fedorov
FGBU NMRC named after V.A. Almazov of the Ministry of Health of the Russian Federation
Email: tvoiurolog@gmail.com
ORCID iD: 0000-0002-6371-4620
assistant at the Department of Urology with Department of Urology with a course of Robotic surgery with a clinic
Russian Federation, Saint PetersburgM. A. Simonenko
FGBU NMRC named after V.A. Almazov of the Ministry of Health of the Russian Federation
Email: dr.maria.simonenko@gmail.com
ORCID iD: 0000-0003-3228-1188
researcher of the Research Laboratory of Cardiopulmonary Testing, transplant cardiologist of Clinical and Diagnostic Center
Russian Federation, Saint PetersburgReferences
- Ferlay J., Colombet M., Soerjomataram I., Parkin D.M., Piñeros M., Znaor A., Bray F. Cancer statistics for the year 2020: An overview. International Journal of Cancer. 2021;149(4):778–789.
- Malignant neoplasms in Russia in 2017 (morbidity and mortality). Ed. A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow, 2019.
- The state of cancer care for the population of Russia in 2018. Ed. A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow, 2019.
- Kaprin A.D., Alekseev Bla, Matveev V.B., Pushkar’ DIu, Govorov A.V., Gorban’ N.A., Kirichek A.A., Biriukov V.A., Volkova M.I., Gulidov I.A., Gumenetskaia luV, Krylov VV, Kariakin OB, Krasheninnikov AA, Mardynskii lu.S, Niushko K.M., Zakharova T.l., Kostin A.A., Khmelevskii E.V., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Zh.V., Gevorkian T.G. Prostate cancer. Clinical recommendations. Journal of Modern Oncology. 2021;23(2):211–247. doi: 10.26442/18151434.2021.2.200959.
- Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
- Chen P.L., Chang H.H., Chen I.M., Lai S.T., Shih C.C., Weng Z.C., Hsieh Y.C., Yang A.H. Malignancy after heart transplantation. Journal of the Chinese Medical Association. 2009;72(11):588–593.
- Lateef N., Abdul Basit K., Abbasi N., Kazmi S.M., Ansari A.B., Shah M. Malignancies after heart transplant. Exp Clin Transplant. 2016;14(1):12–16.
- Mudigonda P., Berardi C., Chetram V., Barac A., Cheng R. Implications of cancer prior to and after heart transplantation. Heart. 2022;108(6):414–421.
- Knipper S., Ott S., Schlemmer H.P., Grimm M.O., Graefen M., Wiegel T. Options for curative treatment of localized prostate cancer. Deutsches Ärzteblatt International. 2021;118(13):228.
- Singh Z., Holt S.K., Gore J.L., Nyame Y.A., Wright J.L., Schade G.R. Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation. European Urology Open Science. 2022;39:79–82.
- Hall E.C., Pfeiffer R.M., Segev D.L., Engels E.A. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013;119(12):2300–2308.
- Collett D., Mumford L., Banner N.R., Neuberger J., Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. American Journal of Transplantation. 2010;10(8):1889–1896.
- Liauw S.L., Ham S.A., Das L.C., Rudra S., Packiam V.T., Koshy M., Weichselbaum R.R., Becker Y.T., Bodzin A.S., Eggener S.E. Prostate cancer outcomes following solid-organ transplantation: a SEER-Medicare analysis. JNCI: Journal of the National Cancer Institute. 2020;112(8):847–854.
- Oh S.C., Tariq M.B., Reddy C.A., Ciezki J.P., Stephans K.L., Tendulkar R.D. Outcomes in organ transplant recipients with prostate cancer treated with radiotherapy. Clinical Genitourinary Cancer. 2019;17(1):e162-6.
- Coombs C.C., Hertzfeld K., Barrett W. Outcomes in transplant patients undergoing brachytherapy for prostate cancer. American journal of clinical oncology. 2012;35(1):40–44.
- Ciancio G., Antun R.A., Norberg D.G., Mitrani A.A., de Marchena E., Soloway MS.. Prostate cancer after heart transplantation. The Journal of urology. 1995;153(1):158–160.
- Axcrona K., Vlatkovic L., Hovland J., Brennhovd B., Kongsgaard U., Giercksky K.E. Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation. Journal of robotic surgery. 2012;6(1):81–83.
- Singh I., Patel B.N., Thohan V., Hemal A.K. Robot-assisted laparoscopic radical prostatectomy after heart transplantation. Urology Annals. 2013;5(1):56.
- Rose K., Arora K., Faraj K., Scott D., Castle E., Andrews P., Ferrigni R. MP67-15 robot assisted radical prostatectomy with solid organ transplantation: surgical technique, complications, and oncologic outcomes. The Journal of Urology. 2020;203 (Suppl. 4):e1031.
- Al-Shukri S.Kh., Mosoyan M.S., Semenov D.Yu., Ilyin D.M. Experience of 424 robot-assisted interventions in St. Petersburg: radical prostatectomy, kidney resection and nephrectomy. Vestnik Khirurgii Imeni I.I. Grekova. 2016;175(5):74–77.
Supplementary files
